Novo A/S

Average Profitability
10.62%
Insider Buys Quantity
22
Insider Buys Sum
$186.68M
Insider Sells Quantity
35
Insider Sells Sum
$321.65M

Insider Activity of Novo A/S

According to the SEC Form 4 filings, Novo A/S, being in a position of

  1. 10 percent owner at IO Biotech, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1392618 shares for $1.89M,
    over all time since 2021-11-09, has bought 2794135 shares for $9.55M, and sold 1392618 shares for $1.89M.

The largest purchase of all time was on 2022-02-08 and amounted to 1666666 shares of Arcellx, Inc. for $25M.

The largest sale of all time was on 2014-11-04 and amounted to 4000000 shares of Inogen, Inc. for $86M.

Biography of Novo A/S

No biography is available at this moment.

2024-07-26SaleIO Biotech, Inc.
IOBT
10 percent owner
23,478
0.0362%
$1.31$30,787-8.53%
2024-07-25SaleIO Biotech, Inc.
IOBT
10 percent owner
51,522
0.0774%
$1.33$68,339-11.57%
2024-05-10SaleIO Biotech, Inc.
IOBT
10 percent owner
658,809
0.8518%
$1.22$802,495-18%
2024-03-21SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
465,021
1.1289%
$0.75$350,951-27.23%
2024-03-20SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
359,979
0.8709%
$0.73$264,081-26.4%
2024-03-19SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
593,000
1.4693%
$0.76$447,715-26.59%
2024-03-18SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
842,020
2.0939%
$0.77$647,008-27.43%
2024-03-14SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
1.91M
0.8272%
$0.89$1.7M-33.17%
2024-02-09SaleIO Biotech, Inc.
IOBT
10 percent owner
658,809
0.8023%
$1.50$988,411-14.42%
2023-08-09PurchaseIO Biotech, Inc.
IOBT
10 percent owner
2.47M
9.534%
$2.02$5M-18.06%
2023-02-16PurchaseSpruce Biosciences, Inc.
SPRB
10 percent owner
2.21M
0.0087%
$3.17$7M-11.16%
2022-09-14PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
484,496
0.9211%
$10.32$5M-14.66%
2022-02-08PurchaseArcellx, Inc.
ACLX
10 percent owner
1.67M
6.7728%
$15.00$25M+6.58%
2021-11-09PurchaseIO Biotech, Inc.
IOBT
10 percent owner
325,000
7.8787%
$14.00$4.55M-62.27%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
10 percent owner
700,000
4.5226%
$19.00$13.3M-7.41%
2021-06-02SaleInogen, Inc.
INGN
10 percent owner
680,000
2.9808%
$57.32$38.98M-41.64%
2021-05-19SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
475,000
1.8365%
$13.90$6.6M-71.54%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
1.25M
1.3005%
$16.00$20M-42.5%
2021-03-01SaleInogen, Inc.
INGN
10 percent owner
790,000
3.2841%
$49.00$38.71M-7.32%
2021-01-28SaleInozyme Pharma, Inc.
INZY
10 percent owner
375,000
1.469%
$21.00$7.88M-30.07%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.